Burkhardt Jan-Karl, Chua Michelle H J, Weiss Miriam, Do Angelique Sao-Mai S, Winkler Ethan A, Lawton Michael T
Department of Neurological Surgery, University of California San Francisco, San Francisco, California.
Department of Neurological Surgery, University of California San Francisco, San Francisco, California.
World Neurosurg. 2017 Oct;106:74-84. doi: 10.1016/j.wneu.2017.06.110. Epub 2017 Jun 23.
Established guidelines for radiologic surveillance after microsurgical treatment of intracranial aneurysms are lacking in the literature because of small sample sizes, poor definitions, and heterogeneous use of imaging modalities. We aimed to propose clinically meaningful definitions for postoperative aneurysm residual, recurrence, and de novo aneurysm formation and to analyze our long-term follow-up catheter angiography results in patients with microsurgically treated intracranial aneurysms.
A retrospective review of all aneurysms treated microsurgically in a consecutive, single-surgeon series from 1997 to present identified patients with long-term follow-up catheter angiography (>1 year after surgery). Clinical and radiologic data were collected for analysis.
We identified 240 patients harboring 380 aneurysms (mean follow-up time, 6.0 ± 3.3 years per patient; range, 1.0-16.8 years). Postoperative residuals were present in 16 out of 346 clipped aneurysms (4.6%), of which only 3 were left unintentionally. Two out of 16 residual aneurysms (12.5%) demonstrated regrowth, with a regrowth risk of 2.1% per year from 93.6 patient-years of angiographic follow-up. Of 326 aneurysms with no postoperative residual, 5 (1.5%) demonstrated aneurysm recurrence, with a recurrence risk of 0.26% per year from 1931.9 patient-years of angiographic follow-up. Eight de novo aneurysms were identified in 240 patients (3.3%), with a risk of 0.6% per year from 1441.9 patient-years of angiographic follow-up.
Microsurgically treated aneurysms have a very low risk of postoperative residuals and aneurysm recurrence. Growth of residuals and de novo aneurysm formation justify following up with catheter angiography 3 to 5 years after microsurgical clipping.
由于样本量小、定义不明确以及成像方式的使用不统一,目前文献中缺乏关于颅内动脉瘤显微手术治疗后放射学监测的既定指南。我们旨在提出关于术后动脉瘤残留、复发和新生动脉瘤形成的具有临床意义的定义,并分析我们对接受显微手术治疗的颅内动脉瘤患者进行长期随访的导管血管造影结果。
对1997年至今由同一外科医生连续治疗的所有接受显微手术的动脉瘤患者进行回顾性研究,确定有长期随访导管血管造影(术后>1年)的患者。收集临床和放射学数据进行分析。
我们确定了240例患者,共380个动脉瘤(每位患者的平均随访时间为6.0±3.3年;范围为1.0 - 16.8年)。在346个夹闭的动脉瘤中,有16个出现术后残留(4.6%),其中只有3个是无意遗留的。16个残留动脉瘤中有2个(12.5%)出现瘤体再生长,在93.6患者年的血管造影随访中,每年的再生长风险为2.1%。在326个无术后残留的动脉瘤中,有5个(1.5%)出现动脉瘤复发,在1931.9患者年的血管造影随访中,每年的复发风险为0.26%。在240例患者中发现8个新生动脉瘤(3.3%),在1441.9患者年的血管造影随访中,每年的风险为0.6%。
显微手术治疗的动脉瘤术后残留和动脉瘤复发风险非常低。残留瘤体生长和新生动脉瘤形成表明在显微手术夹闭后3至5年需要进行导管血管造影随访。